COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
27/08/2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two [...]
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
27/08/2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative [...]
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
27/08/2025
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
27/08/2025
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug [...]
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
27/08/2025
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27 th Annual Global Investment Conference being [...]
Bicara Therapeutics to Participate in Upcoming Investor Conferences
27/08/2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Metsera to Present at Upcoming September Investor Conferences
27/08/2025
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
27/08/2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Cytokinetics to Participate in September Investor Conferences
27/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences [...]
KFSHRC’s 24/7 Emergency Virtual Clinic Serves Over 23,500 Patients in First Year
27/08/2025
RIYADH, Saudi Arabia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) announced that its 24/7 Emergency Department (ED) Virtual Clinic has delivered more than 23,500 [...]
Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure
27/08/2025
WARREN, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today updated investors of its significant internally developed assets, which under U.S. GAAP [...]
Quest PharmaTech Announces Results from AGM
27/08/2025
EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders. The Company [...]
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
27/08/2025
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will begin immediately to [...]
Ipsen - July 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
27/08/2025
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Juillet 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
27/08/2025
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand
27/08/2025
HONG KONG, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in AI-driven Internet healthcare solutions, reported a profitable first half of 2025, supported by an [...]
Ramsay Sante : Provisional annual Results at the end of June 2025
27/08/2025
PRESS RELEASE Paris, 27 th August 2025 Provisional annual results at the end of June 2025 Revenue growth of 4.7% and Group EBITDA up 1.7% despite reduction in public funding; secured long term financing framework [...]
RAMSAY SANTE : résultats annuels provisoires à fin juin 2025
27/08/2025
COMMUNIQUÉ DE PRESSE Paris, le 27 août 2025 Résultats annuels provisoires à fin juin 2025 Croissance du chiffre d'affaires de 4,7 % et EBITDA en hausse de 1,7 % malgré une baisse du financement public ; structure de [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
27/08/2025
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 27 aout 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Pages